Chemokine IP-10: An adjunct marker for latent tuberculosis infection in children

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 6, 2009, Pages 731-736

  Lighter, Jennifer ^a   Rigaud, M ^a   Huie, M ^a   Peng, C H ^a   Pollack, H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Interferon gamma release assay; IP 10

Indexed keywords

CHEMOKINE; CHEMOKINE INDUCIBLE PROTEIN 10; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN SPECIFICITY; ARTICLE; ASSAY; BLOOD; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HUMAN; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; STIMULATION; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHEMOKINE CXCL10; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; NEW YORK CITY; REAGENT KITS, DIAGNOSTIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 59649094692     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2008. WHO/HTM/TB/2008.393. Geneva, Switzerland: WHO, 2008.
2. Smith S, Jacobs R F, Wilson C B. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr 1997; 131: 16-26. (Pubitemid 27498304)
3. Aubert-Pivert E M, Chedevergne F M, Lopez-Ramirez G M, et al. Cytokine transcripts in pediatric tuberculosis: a study with bronchoalveolar cells. Tubercle Lung Dis 2000; 80: 249-258.
4. Lighter J R M, Eduardo R, Peng C-H, Pollack H. Latent tuberculosis infection in children using the QuantiFERON-Gold In-Tube. Pediatrics 2009; 123: 30-37.
5. Connell T G, Curtis N, Ranganathan S C, Buttery J P. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006; 61: 616-620.
6. Farber J M. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997; 61: 246-257. (Pubitemid 27149903)
7. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 2007; 9: 806-812. (Pubitemid 46901043)
8. Azzurri A, Sow O Y, Amedei A, et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 2005; 7: 1-8.
9. Juffermans N P, Verbon A, van Deventer S J, et al. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun 1999; 67: 4295-4297. (Pubitemid 29357063)
10. Ruhwald M, Petersen J, Kofoed K, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 2008; 3: e2858.
11. Ng P C, Li K, Chui K M, et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 2007; 61: 93-98. (Pubitemid 46352323)
12. Sullivan S E, Staba S L, Gersting J A, et al. Circulating concentrations of chemokines in cord blood, neonates and adults. Pediatr Res 2002; 51: 653-657. (Pubitemid 34453585)
13. Fotopoulos S, Mouchtouri A, Xanthou G, Lipsou N, Petrakou E, Xanthou M. Inflammatory chemokine expression in the peripheral blood of neonates with perinatal asphyxia and perinatal or nosocomial infections. Acta Paediatr 2005; 94: 800-806. (Pubitemid 40839818)
14. Trends in tuberculosis - United States, 2005. MMWR 2006; 55: 305-308.
15. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64. (Pubitemid 38997752)
16. Lande R, Giacomini E, Grassi T, et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol 2003; 170: 1174-1182.
17. Mendez Samperio P, Trejo A, Miranda E. Role of type I interferon in the bacillus Calmette-Guerin-induced expression of CXCL10 from human monocytes. Mediators Inflamm 2004; 13: 343-348. (Pubitemid 40018368)
18. Rotondi M, Lazzeri E, Romagnani P, Serio M. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 2003; 26: 177-180. (Pubitemid 36503068)
19. Jain V, Armah H B, Tongren J E, et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 2008; 7: 83. (Pubitemid 351754711)
20. Antonelli A, Ferri C, Fallahi P, et al. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Am J Gastroenterol 2008; 103: 2488-2494.
21. Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFN gamma? PLoS One 2008; 3: e3901.
22. Ferrero E, Biswas P, Vettoretto K, et al. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells. Immunology 2003; 108: 365-374. (Pubitemid 36332395)
23. National Tuberculosis Controllers Association and Centers for Disease Prevention and Control (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 2005; 54: 1-47.
24. Petrucci R, Abu Amer N, Gurgel R Q, et al. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J 2008; 27: 1073-1077.